Targeting potential of antibody conjugates.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 6361806)

Published in Pharmacol Ther on January 01, 1983

Authors

D C Edwards

Articles by these authors

Ideal observer approximation using Bayesian classification neural networks. IEEE Trans Med Imaging (2001) 1.51

The adjuvant properties of liposomes. Biochem Soc Trans (1976) 1.30

Formation of virosomes from influenza subunits and liposomes. Lancet (1975) 1.22

The preparation and properties of horse antihuman lymphocyte serum and globulin. Transplantation (1970) 1.18

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin. Eur J Biochem (1981) 1.15

Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin. Nature (1978) 1.14

Transfer of ricin toxicity by spleen cells. Toxicon (1984) 0.95

Immunogenic contaminants in mouse nerve-growth factor. Eur J Biochem (1977) 0.93

Notes on the large scale preparation and on the properties of anti-lymphocyte serum for use in mice. Techniques. Clin Exp Immunol (1970) 0.93

Studies on the isolation of epithelial growth factor from fractions of mouse salivary-gland extracts. Biochem J (1970) 0.92

Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment. Eur J Biochem (1980) 0.91

Distribution and immunology of mammalian nerve growth factor. Nature (1974) 0.85

Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity. Clin Exp Immunol (1972) 0.84

Axonal regeneration of peripheral adrenergic neurons: effects of antiserum to nerve growth factor in mouse. Cell Tissue Res (1974) 0.83

Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agent. FEBS Lett (1983) 0.82

A study of the de- and regenerative changes in the sympathetic nervous system of the adult mouse after treatment with the antiserum to nerve growth factor. Brain Res (1975) 0.81

Antigen differences, detected by indirect immunofluorescence, between human peripheral and thoracic duct lymphocytes, and human cultured lymphoblasts. Clin Exp Immunol (1973) 0.81

Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin. Clin Exp Immunol (1981) 0.79

Stimulus intensity and recency contrasts and orienting response strength. Psychophysiology (1974) 0.77

The administration of the nerve growth factor to children with widespread neuroblastoma. J Pediatr Surg (1970) 0.76

Effects of nerve growth factors from mouse salivary glands and snake venom on the sympathetic ganglia of neonatal and developing mice. J Physiol (1975) 0.76

OCAW objects to random drug testing. Occup Health Saf (1986) 0.75

Employees have a right to know. Forum. Manage Rev (1986) 0.75

Nerve growth factor and pancreatic APUD cells. Endocr Res Commun (1980) 0.75

Within mode quality and intensity changes of habituated stimuli. Biol Psychol (1975) 0.75

The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells. Experientia (1981) 0.75

Psychophysiological patterning to psychological processes. Percept Mot Skills (1968) 0.75

Spreed of nonreinforced running response following increasing and decreasing orders of sucrose concentrations. J Exp Psychol (1966) 0.75

Intake-rejection, verbalization, and affect: effects on heart rate and skin conductance. Psychophysiology (1969) 0.75

Peripheral vision location and kinds of complex processing. J Exp Psychol (1974) 0.75

Recovery of haemolytic plaque-forming cells after freeze drying. Nature (1975) 0.75

The assay of solubilised murine histocompatibility antigens and antigens reacting with antilymphocyte serum by inhibition of immunofluorescence. J Immunol Methods (1974) 0.75

A horse anti-human lymphocytic serum for clinical trial in renal homo-transplantation. Br J Surg (1969) 0.75

Obligations of physicians to patients and third-party payers. J Clin Ethics (1994) 0.75

A comparison of the in vitro and in vivo activities of conjugates of anti-mouse lymphocyte globulin and abrin. Biochim Biophys Acta (1982) 0.75

The surface properties of spleen cells from CBA/lac mice following freezing and freeze-drying using polyvinylpyrrolidone. Cryobiology (1976) 0.75

Comparison of first-eye-movement detection methods. Percept Mot Skills (1971) 0.75

Stimulus intensity reduction following habituation. Psychophysiology (1975) 0.75